Literature DB >> 26896596

Biomaterials for enhancing anti-cancer immunity.

Sandeep T Koshy1, David J Mooney2.   

Abstract

Cancer immunotherapy is becoming a standard approach to treat many cancers. However, shortcomings of current methods limit therapeutic benefit in many patients. Rationally designed biomaterial strategies to deliver immune modulatory drugs can potentially show improved safety profiles, while providing multifunctional and spatiotemporally controlled signals to immune cells to improve their anti-cancer activity. This brief review describes biomaterials-based strategies that enhance immune cell function at various tissue sites to improve anti-cancer immunity. Continued collaboration between bioengineers, immunologists, industry, and clinicians is required for biomaterial-based immunotherapy strategies to continue moving to the clinic.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26896596      PMCID： PMC4975655          DOI： 10.1016/j.copbio.2016.02.001

Source DB:  PubMed          Journal:  Curr Opin Biotechnol        ISSN： 0958-1669            Impact factor:   9.740


  52 in total

Review 1.  Hydrogels and scaffolds for immunomodulation.

Authors:  Ankur Singh; Nicholas A Peppas
Journal:  Adv Mater       Date:  2014-08-25       Impact factor: 30.849

2.  Exploiting lymphatic transport and complement activation in nanoparticle vaccines.

Authors:  Sai T Reddy; André J van der Vlies; Eleonora Simeoni; Veronique Angeli; Gwendalyn J Randolph; Conlin P O'Neil; Leslie K Lee; Melody A Swartz; Jeffrey A Hubbell
Journal:  Nat Biotechnol       Date:  2007-09-16       Impact factor: 54.908

3.  Nanoparticle conjugation of CpG enhances adjuvancy for cellular immunity and memory recall at low dose.

Authors:  Alexandre de Titta; Marie Ballester; Ziad Julier; Chiara Nembrini; Laura Jeanbart; André J van der Vlies; Melody A Swartz; Jeffrey A Hubbell
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-18       Impact factor: 11.205

Review 4.  Nanoparticle delivery of cancer drugs.

Authors:  Andrew Z Wang; Robert Langer; Omid C Farokhzad
Journal:  Annu Rev Med       Date:  2011-09-01       Impact factor: 13.739

Review 5.  Lymphatic and interstitial flow in the tumour microenvironment: linking mechanobiology with immunity.

Authors:  Melody A Swartz; Amanda W Lund
Journal:  Nat Rev Cancer       Date:  2012-02-24       Impact factor: 60.716

Review 6.  Immune checkpoint blockade: a common denominator approach to cancer therapy.

Authors:  Suzanne L Topalian; Charles G Drake; Drew M Pardoll
Journal:  Cancer Cell       Date:  2015-04-06       Impact factor: 31.743

Review 7.  Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential.

Authors:  Padmanee Sharma; James P Allison
Journal:  Cell       Date:  2015-04-09       Impact factor: 41.582

Review 8.  Therapeutic cancer vaccines.

Authors:  Cornelis J M Melief; Thorbald van Hall; Ramon Arens; Ferry Ossendorp; Sjoerd H van der Burg
Journal:  J Clin Invest       Date:  2015-07-27       Impact factor: 14.808

9.  Injectable cryogel-based whole-cell cancer vaccines.

Authors:  Sidi A Bencherif; R Warren Sands; Omar A Ali; Weiwei A Li; Sarah A Lewin; Thomas M Braschler; Ting-Yu Shih; Catia S Verbeke; Deen Bhatta; Glenn Dranoff; David J Mooney
Journal:  Nat Commun       Date:  2015-08-12       Impact factor: 14.919

10.  Induction of potent anti-tumor responses while eliminating systemic side effects via liposome-anchored combinatorial immunotherapy.

Authors:  Brandon Kwong; Haipeng Liu; Darrell J Irvine
Journal:  Biomaterials       Date:  2011-04-22       Impact factor: 12.479
View more
  36 in total

1.  Oral delivery of tumor microparticle vaccines activates NOD2 signaling pathway in ileac epithelium rendering potent antitumor T cell immunity.

Authors:  Wenqian Dong; Huafeng Zhang; Xiaonan Yin; Yuying Liu; Degao Chen; Xiaoyu Liang; Xun Jin; Jiadi Lv; Jingwei Ma; Ke Tang; Zhuowei Hu; Xiaofeng Qin; Bo Huang
Journal:  Oncoimmunology       Date:  2017-01-19       Impact factor: 8.110

Review 2.  Biomaterials for vaccine-based cancer immunotherapy.

Authors:  Rui Zhang; Margaret M Billingsley; Michael J Mitchell
Journal:  J Control Release       Date:  2018-10-09       Impact factor: 9.776

Review 3.  Advances in engineering local drug delivery systems for cancer immunotherapy.

Authors:  Peter Abdou; Zejun Wang; Qian Chen; Amanda Chan; Daojia R Zhou; Vivienne Gunadhi; Zhen Gu
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2020-04-07

Review 4.  Advances in immunotherapy delivery from implantable and injectable biomaterials.

Authors:  David G Leach; Simon Young; Jeffrey D Hartgerink
Journal:  Acta Biomater       Date:  2019-02-13       Impact factor: 8.947

5.  Tumor microenvironment after biodegradable BCNU wafer implantation: special consideration of immune system.

Authors:  Ichiyo Shibahara; Mitsuto Hanihara; Takashi Watanabe; Mitsuru Dan; Sumito Sato; Hiroki Kuroda; Akinori Inamura; Madoka Inukai; Atsuko Hara; Yoshie Yasui; Toshihiro Kumabe
Journal:  J Neurooncol       Date:  2018-02-21       Impact factor: 4.130

6.  Injectable, Tough Alginate Cryogels as Cancer Vaccines.

Authors:  Ting-Yu Shih; Serena O Blacklow; Aileen W Li; Benjamin R Freedman; Sidi Bencherif; Sandeep T Koshy; Max C Darnell; David J Mooney
Journal:  Adv Healthc Mater       Date:  2018-02-14       Impact factor: 9.933

7.  Inflammation-Triggered Cancer Immunotherapy by Programmed Delivery of CpG and Anti-PD1 Antibody.

Authors:  Chao Wang; Wujin Sun; Grace Wright; Andrew Z Wang; Zhen Gu
Journal:  Adv Mater       Date:  2016-08-25       Impact factor: 30.849

8.  Surface Coating of Nanoparticles Reduces Background Inflammatory Activity while Increasing Particle Uptake and Delivery.

Authors:  Brittany A Moser; Rachel C Steinhardt; Aaron P Esser-Kahn
Journal:  ACS Biomater Sci Eng       Date:  2016-12-01

9.  Anti-tumor immunity induced by ectopic expression of viral antigens is transient and limited by immune escape.

Authors:  Neeraja Dharmaraj; Stacey L Piotrowski; Chen Huang; Jared M Newton; Leonard S Golfman; Aurelie Hanoteau; Sandeep T Koshy; Aileen W Li; Merlyn X Pulikkathara; Bing Zhang; Jared K Burks; David J Mooney; Yu L Lei; Andrew G Sikora; Simon Young
Journal:  Oncoimmunology       Date:  2019-02-06       Impact factor: 8.110

10.  Liposomal Delivery Enhances Immune Activation by STING Agonists for Cancer Immunotherapy.

Authors:  Sandeep T Koshy; Alexander S Cheung; Luo Gu; Amanda R Graveline; David J Mooney
Journal:  Adv Biosyst       Date:  2017-01-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.